Ceylinco Life closes 2019 with PBT Rs.8.2Bn, Revenue of Rs.32.1Bn

Ceylinco-Life-Head-Office

Feb 19, 2020 (LBO) - Ceylinco Life has ended 2019 on a characteristically strong note, with consolidated income of 32.1 billion rupees for the 12 months ending 31st December 2019, reflecting top line growth of 9.9 percent.

The life insurance frontrunner has reported gross written premium income of Rs 18.

online pharmacy buy valtrex with best prices today in the USA


online pharmacy buy avodart with best prices today in the USA


buy elavil online https://lifepractice.net/wp-content/uploads/2022/08/png/elavil.html no prescription pharmacy

7 billion, an increase of Rs 906 million or 5 percent over 2018, and investment and other income of Rs 13.4 billion, an improvement of 17.
online pharmacy buy diflucan with best prices today in the USA


buy albenza online https://lifepractice.net/wp-content/uploads/2022/08/png/albenza.html no prescription pharmacy

5 percent.

The premium income recorded for 2019 establishes Ceylinco Life as the market leader for life insurance in Sri Lanka for the 16th consecutive year.

The Company has posted profit before tax of Rs 8.


2 billion, up 14.7 percent and net profit of Rs 6.
online pharmacy buy abilify with best prices today in the USA




buy zoloft online https://lifepractice.net/wp-content/uploads/2022/08/png/zoloft.html no prescription pharmacy

7 billion, a robust growth of 15.1 percent.

“These figures are impressive by any standards considering the depressed economic conditions they were achieved in,” Ceylinco Life Managing Director/CEO Mr Thushara Ranasinghe said. “It was a challenging year for financial services companies, as is evident from the results already published by many. We attribute our performance to our unwavering focus, sharpened over many years, on the fundamental principles of our business and on strict conformity with core values at all times.”

Ceylinco Life’s investment portfolio grew by an impressive 12.7 per cent over the 12 months to Rs 116.9 billion as at 31st December 2019, while total assets increased by 13 per cent to Rs 133.4 billion.

The Company’s Life Fund grew by 9.2 per cent to Rs 96.2 billion. Shareholders’ funds increased by Rs 3.9 billion during the year to Rs 31.

online pharmacy buy spiriva inhaler with best prices today in the USA


online pharmacy buy glucophage with best prices today in the USA

5 billion.

Ceylinco Life paid Rs 10.6 billion in net claims and benefits to policyholders, which reflects an increase of 8.1 per cent over the figure for 2018.

online pharmacy buy keflex with best prices today in the USA


online pharmacy buy keflex with best prices today in the USA

The market leader in Sri Lanka’s life insurance industry for 16 of the 32 years it has been in operation, Ceylinco Life has close to a million lives covered by active policies and is acknowledged as a benchmark in the local insurance industry for innovation, product research and development, customer service, professional development and corporate social responsibility.

Ceylinco Life was adjudged Sri Lanka’s most valuable life insurance brand by Brand Finance in 2019, ranked among the 10 ‘Most Admired Companies’ in the country by the ICCSL the same year, named the Best Life Insurer in Sri Lanka for the sixth consecutive year in 2019 by World Finance, and has also been declared the most popular life insurance company in the country for the past 13 years by SLIM-Nielsen.

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
Top
0
Would love your thoughts, please comment.x
()
x